Hippo Labs Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimhip MV 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimhip MV 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimhip MV 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimhip MV 2mg/500mg/0.2mg Tablet.
Glimhip MV 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimhip MV 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimhip MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glimhip MV 2mg/500mg/0.2mg Tablet contains three active ingredients: Glimepiride, Metformin and Voglibose. This medicine is used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken with a healthy diet and regular exercise. Glimepiride helps lower blood glucose by increasing insulin release from the pancreas. Metformin decreases glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) blood glucose levels.
Common side effects associated with Glimhip MV 2mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Glimhip MV 2mg/500mg/0.2mg Tablet should not be used if you have an allergy to any of the ingredients or excipients in this medicine. It's also advised against use for patients with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining alcohol with Glimhip MV 2mg/500mg/0.2mg Tablet is not advisable. It can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, the use of Glimhip MV 2mg/500mg/0.2mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a fast heartbeat, and feelings of anxiety or shakiness. Hypoglycemia is more likely when you skip meals, drink alcohol, over-exercise, or take other diabetes medications along with it. Regular monitoring of blood sugar levels is crucial.
Store this medicine in its original container or packaging, tightly closed. Follow the instructions on the label for proper storage. If you have unused medication, dispose of it properly, ensuring it is not accessible to pets, children, or other people.